Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease

Chiung Chi Peng, Chiu Lan Hsieh, Yaw Bee Ker, Hsi Yi Wang, Kuan Chou Chen, Robert Y. Peng

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Scope: The number of patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and specific pharmacologic options are recommended. Some nutraceutics may have benefits in this regard. Methods and results: Naringenin (a flavanon), catechin (a flavanol), and quercetin (a flavonol) and rutin (a flavonol rutinoside) were tried on CKD in a Sprague Dawley rat model. Results indicated quercetin to be the most effective therapeutic candidate with respect to renal edema, hypertension, serum creatinine, hematocrit, cardiopathy, aorta calcification, glomerular amyloidosis, erythrocyte depletion in bone marrow, collagen deposition, expressions of TNF-α, cleaved caspase-3, IκBα, PPARα, and serum insulin. But quercetin was only partially effective in restoring glomerular filtration rate, albuminuria, serum cholesterol, triglyceride, blood urea nitrogen (BUN), uric acid, malondialdehyde, superoxide dismutase; urinary BUN and urinary creatinine. As for signaling, quercetin was completely effective in alleviating the cleaved caspase-3, being only partially effective in suppressing Bax and Bad, restoring Bcl-2, and rescuing DNA damage. Conclusion: The CKD status cannot to be ameliorated by naringenin, rutin, and catechin. Comparatively, quercetin may be a better therapeutic candidate.

Original languageEnglish
Pages (from-to)1541-1558
Number of pages18
JournalMolecular Nutrition and Food Research
Volume56
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

doxorubicin
Quercetin
Therapeutic Uses
kidney diseases
Chronic Renal Insufficiency
quercetin
Doxorubicin
screening
rutin
therapeutics
blood serum
Rutin
naringenin
Catechin
Blood Urea Nitrogen
caspase-3
urea nitrogen
catechin
flavonols
Caspase 3

Keywords

  • Apoptosis
  • Chronic kidney disease
  • Cytokines
  • Hyperlipidemia
  • Quercetin

ASJC Scopus subject areas

  • Food Science
  • Biotechnology

Cite this

Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease. / Peng, Chiung Chi; Hsieh, Chiu Lan; Ker, Yaw Bee; Wang, Hsi Yi; Chen, Kuan Chou; Peng, Robert Y.

In: Molecular Nutrition and Food Research, Vol. 56, No. 10, 10.2012, p. 1541-1558.

Research output: Contribution to journalArticle

Peng, Chiung Chi ; Hsieh, Chiu Lan ; Ker, Yaw Bee ; Wang, Hsi Yi ; Chen, Kuan Chou ; Peng, Robert Y. / Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease. In: Molecular Nutrition and Food Research. 2012 ; Vol. 56, No. 10. pp. 1541-1558.
@article{9c43adcc0ab2454bbc04da2523c6f93f,
title = "Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease",
abstract = "Scope: The number of patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and specific pharmacologic options are recommended. Some nutraceutics may have benefits in this regard. Methods and results: Naringenin (a flavanon), catechin (a flavanol), and quercetin (a flavonol) and rutin (a flavonol rutinoside) were tried on CKD in a Sprague Dawley rat model. Results indicated quercetin to be the most effective therapeutic candidate with respect to renal edema, hypertension, serum creatinine, hematocrit, cardiopathy, aorta calcification, glomerular amyloidosis, erythrocyte depletion in bone marrow, collagen deposition, expressions of TNF-α, cleaved caspase-3, IκBα, PPARα, and serum insulin. But quercetin was only partially effective in restoring glomerular filtration rate, albuminuria, serum cholesterol, triglyceride, blood urea nitrogen (BUN), uric acid, malondialdehyde, superoxide dismutase; urinary BUN and urinary creatinine. As for signaling, quercetin was completely effective in alleviating the cleaved caspase-3, being only partially effective in suppressing Bax and Bad, restoring Bcl-2, and rescuing DNA damage. Conclusion: The CKD status cannot to be ameliorated by naringenin, rutin, and catechin. Comparatively, quercetin may be a better therapeutic candidate.",
keywords = "Apoptosis, Chronic kidney disease, Cytokines, Hyperlipidemia, Quercetin",
author = "Peng, {Chiung Chi} and Hsieh, {Chiu Lan} and Ker, {Yaw Bee} and Wang, {Hsi Yi} and Chen, {Kuan Chou} and Peng, {Robert Y.}",
year = "2012",
month = "10",
doi = "10.1002/mnfr.201200178",
language = "English",
volume = "56",
pages = "1541--1558",
journal = "Molecular Nutrition and Food Research",
issn = "1613-4125",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease

AU - Peng, Chiung Chi

AU - Hsieh, Chiu Lan

AU - Ker, Yaw Bee

AU - Wang, Hsi Yi

AU - Chen, Kuan Chou

AU - Peng, Robert Y.

PY - 2012/10

Y1 - 2012/10

N2 - Scope: The number of patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and specific pharmacologic options are recommended. Some nutraceutics may have benefits in this regard. Methods and results: Naringenin (a flavanon), catechin (a flavanol), and quercetin (a flavonol) and rutin (a flavonol rutinoside) were tried on CKD in a Sprague Dawley rat model. Results indicated quercetin to be the most effective therapeutic candidate with respect to renal edema, hypertension, serum creatinine, hematocrit, cardiopathy, aorta calcification, glomerular amyloidosis, erythrocyte depletion in bone marrow, collagen deposition, expressions of TNF-α, cleaved caspase-3, IκBα, PPARα, and serum insulin. But quercetin was only partially effective in restoring glomerular filtration rate, albuminuria, serum cholesterol, triglyceride, blood urea nitrogen (BUN), uric acid, malondialdehyde, superoxide dismutase; urinary BUN and urinary creatinine. As for signaling, quercetin was completely effective in alleviating the cleaved caspase-3, being only partially effective in suppressing Bax and Bad, restoring Bcl-2, and rescuing DNA damage. Conclusion: The CKD status cannot to be ameliorated by naringenin, rutin, and catechin. Comparatively, quercetin may be a better therapeutic candidate.

AB - Scope: The number of patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and specific pharmacologic options are recommended. Some nutraceutics may have benefits in this regard. Methods and results: Naringenin (a flavanon), catechin (a flavanol), and quercetin (a flavonol) and rutin (a flavonol rutinoside) were tried on CKD in a Sprague Dawley rat model. Results indicated quercetin to be the most effective therapeutic candidate with respect to renal edema, hypertension, serum creatinine, hematocrit, cardiopathy, aorta calcification, glomerular amyloidosis, erythrocyte depletion in bone marrow, collagen deposition, expressions of TNF-α, cleaved caspase-3, IκBα, PPARα, and serum insulin. But quercetin was only partially effective in restoring glomerular filtration rate, albuminuria, serum cholesterol, triglyceride, blood urea nitrogen (BUN), uric acid, malondialdehyde, superoxide dismutase; urinary BUN and urinary creatinine. As for signaling, quercetin was completely effective in alleviating the cleaved caspase-3, being only partially effective in suppressing Bax and Bad, restoring Bcl-2, and rescuing DNA damage. Conclusion: The CKD status cannot to be ameliorated by naringenin, rutin, and catechin. Comparatively, quercetin may be a better therapeutic candidate.

KW - Apoptosis

KW - Chronic kidney disease

KW - Cytokines

KW - Hyperlipidemia

KW - Quercetin

UR - http://www.scopus.com/inward/record.url?scp=84867054038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867054038&partnerID=8YFLogxK

U2 - 10.1002/mnfr.201200178

DO - 10.1002/mnfr.201200178

M3 - Article

C2 - 22945467

AN - SCOPUS:84867054038

VL - 56

SP - 1541

EP - 1558

JO - Molecular Nutrition and Food Research

JF - Molecular Nutrition and Food Research

SN - 1613-4125

IS - 10

ER -